- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Raytel implements reverse stock split
On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from
On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from approximately 8.8 million to 2.9 million. Shareholders have been asked to return their stock certificates representing shares of the old common stock. They will be given cash, based on the May 23 closing price, in lieu of any fractional shares. On May 24, trading closed at $1.8 per share. The upward swing continued, with Raytel closing May 30 at $2.25.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
